|
|
Article: SCOLR and Dr Reddy's enter licensing deal.(SCOLR Pharma)(Dr Reddy's Laboratories)(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- October 29, 2007
CopyrightCOPYRIGHT 2007 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SCOLR Pharma has entered into a collaboration and license agreement with India-headquartered Dr Reddy's Laboratories. The parties will pursue the development and commercialization of an undisclosed oral prescription drug with significant potential for the cardiopulmonary market utilizing SCOLR's CDT technology.
Under the terms of the deal, Dr Reddy's will be responsible for the development, manufacturing and marketing of the drug, with SCOLR doing ...
Related newspaper, magazine, and journal articles:
|
|
Article: SCOLR Pharma Announces Worldwide Licensing ...
Business Wire;
December 22, 2005 ;
700+ words
...BELLEVUE, Wash. -- SCOLR Pharma, Inc. (Amex: DDD) announced ... the worldwide rights to utilize SCOLR Pharma's proprietary and patented CDT ... Wyeth Consumer Healthcare will pay SCOLR Pharma an upfront licensing fee, and ...
|
|